J
Jonhan Ho
Researcher at University of Pittsburgh
Publications - 84
Citations - 1987
Jonhan Ho is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Digital pathology. The author has an hindex of 17, co-authored 77 publications receiving 1673 citations.
Papers
More filters
Journal ArticleDOI
Diagnostic Inaccuracy of Smartphone Applications for Melanoma Detection
Joel Wolf,Jacqueline F. Moreau,Oleg E. Akilov,Timothy Patton,Joseph C. English,Jonhan Ho,Laura K. Ferris +6 more
TL;DR: The performance of smartphone applications in assessing melanoma risk is highly variable, and 3 of 4 smartphone applications incorrectly classified 30% or more of melanomas as unconcerning.
Journal ArticleDOI
Use of whole slide imaging in surgical pathology quality assurance: design and pilot validation studies.
TL;DR: A retrospective comparative study in which 24 full genitourinary cases were independently reviewed with traditional microscopy and whole slide digital images, it is agreed that automated WSI is a viable potential modality for surgical pathology QA, especially in multifacility health systems that would like to establish interfacility QA.
Journal ArticleDOI
Primary histologic diagnosis using automated whole slide imaging: a validation study
TL;DR: The results indicated that the image information contained in current whole slide images is sufficient for pathologists to make reliable diagnostic decisions and compose complex diagnostic reports, but this does not mean that WSI is as good as a microscope.
Journal ArticleDOI
Importance of glycolysis and oxidative phosphorylation in advanced melanoma
Jonhan Ho,Michelle Barbi de Moura,Yan Lin,Garret Vincent,Stephen H. Thorne,Lyn M. Duncan,Lin Hui-Min,John M. Kirkwood,Dorothea Becker,Bennett Van Houten,Stergios J. Moschos,Stergios J. Moschos +11 more
TL;DR: Analysis of human melanoma specimens using the Seahorse XF24 extracellular flux analyzer indicated that metastatic melanoma tumors derived a large fraction of energy from OXPHOS, suggesting metabolic symbiosis within the same tumor, whereas in stage IV melanomas with high serum LDH glycolysis is the principle source of energy.
Journal ArticleDOI
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Jonathan S. Zager,Brian R. Gastman,Sancy A. Leachman,Rene Gonzalez,Martin D. Fleming,Laura K. Ferris,Jonhan Ho,Alexander R. Miller,Robert W. Cook,Kyle R. Covington,Kristen Meldi-Plasseraud,Brooke Middlebrook,Lewis H. Kaminester,Anthony Greisinger,Sarah Estrada,David M. Pariser,Lee D. Cranmer,Jane L. Messina,John T. Vetto,Jeffrey D. Wayne,Keith A. Delman,David H. Lawson,Pedram Gerami +22 more
TL;DR: The GEP test is an objective predictor of metastatic risk and provides additional independent prognostic information to traditional staging to help estimate an individual’s risk for recurrence.